Astrana Health (ASTH) Gains from Investment Securities (2015 - 2026)

Astrana Health has disclosed Gains from Investment Securities across 11 years of filings, most recently posting -$1.2 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at -$1.2 million, down 120.18% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.9 million (down 153.14% YoY), and the FY2025 annual result was $174824.0, down 55.01% from the prior year.
• Gains from Investment Securities came in at -$1.2 million for Q1 2026 at Astrana Health, up from -$7.8 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $5.7 million in Q1 2025 to a low of -$7.8 million in Q4 2025.
• The 5-year median for Gains from Investment Securities is $233500.0 (2022), against an average of $572552.1.
• Peak annual rise in Gains from Investment Securities reached 12492.93% in 2025, while the deepest fall reached 490.37% in 2025.
• Astrana Health's Gains from Investment Securities stood at $138000.0 in 2022, then surged by 135.51% to $325000.0 in 2023, then surged by 513.23% to $2.0 million in 2024, then plunged by 490.37% to -$7.8 million in 2025, then jumped by 85.14% to -$1.2 million in 2026.
• The last three Gains from Investment Securities figures came in at -$1.2 million (Q1 2026), -$7.8 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.